Page last updated: 2024-10-24

bupivacaine and HIV Coinfection

bupivacaine has been researched along with HIV Coinfection in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ribeiro, RMP1
Moreira, FL1
Moisés, ECD1
Cavalli, RC1
Quintana, SM1
Lanchote, VL1
Duarte, G1

Other Studies

1 other study available for bupivacaine and HIV Coinfection

ArticleYear
Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:10

    Topics: Adult; Amniotic Fluid; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthetics, Local; Bupivacain

2018